Article
Mutational spectrum in clinically aggressive low-grade serous carcinoma/serous borderline tumors of the ovary-Clinical significance of BRCA2 gene variants in genomically stable tumors.
Gynecologic oncology - 1 Jun 2021
Zhang Xiaoming, Devins Kyle, Ko Emily M, Reyes Maria Carolina, Simpkins Fiona, Drapkin Ronny, Schwartz Lauren E, Yoon Ju-Yoon
Abstract excerpt
OBJECTIVE: The mutational spectra of low-grade serous carcinomas (LGSCs) and serous borderline tumors (SBTs) of the ovary are poorly characterized. We present 17 cases of advanced or recurrent LGSC/SBT patients who underwent molecular profiling. METHODS: Thirteen LGSCs and four SBTs underwent targeted gene panel testing by massively parallel sequencing. Microsatellite stability and tumor mutation burdens (TMBs)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
